Skip to main content

Green Pine Capital Partners — Portfolio, Page 3

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

124
Companies
$2.8B
Total invested
$38.4M
Avg. check
43
Industries
Health Care 10Biotechnology 8Medical 7Software 5E-Commerce 3Pharmaceutical 3+37 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 4972 of 124
Ruitai Biotechnology
March 2023

Ruitai Biotechnology is a developer of ophthalmic regenerative medicine.

Health Care · Ningbo$12.9M Series A
Bluepha
February 2023

Bluepha is a biomanufacturing and material innovation company providing breakthrough products with competitive differentiation.

Biotechnology · Beijing$58.6M Series B
InnerMedical
February 2023

InnerMedical is a medical device developer.

Health Care · ShenzhenSeries D
SiBionics
December 2022

SiBionics is a medtech company that engages in the field of chronic disease management.

Artificial Intelligence (AI) · Shenzhen$71.6M Series D
X-EPIC
November 2022

X-EPIC is a Nanjing city-based startup aimed at building up China’s own EDA (Electronic Design Automation) industrial software technology.

Electronics · NanjingSeries B
ZVISION
November 2022

LiDAR, Robotics, Sensors, ADAS, Drones

Automotive · BeijingSeries C
Dobot
July 2022

Dobot is a leading robotic arm solutions provider.

Electronics · ShenzhenSeries Unknown
Insight Technology
July 2022

Insight Technology provides data intelligence solutions by using multi-party computing, federated learning, and blockchain technology.

Blockchain · Beijing$14.9M Series A
Cubenergy Technology
July 2022

Cubenergy Technology is an energy technology company providing energy data operation services.

Battery · ShenzhenSeries B
AMCARELAB
June 2022

AMCARELAB is an independent medical service organization providing diagnosis and consultant for hereditary & oncological diseases.

Biotechnology · Guangzhou$29.9M Series B
Singlera Genomics
June 2022

Singlera Genomics is a fast growing company focusing on non-invasive genetic testing.

Biotechnology · La Jolla$44.9M Series B
LIGOO
March 2022

LIGOO specializes in technical research, product development, and system integration of the battery management system.

Automotive · Hefei$1.6M Series Unknown
Shenzhen Shifeng
March 2022

Shenzhen Shifeng is committed to the independent research and development and industrialization of high-end industrial software.

Simulation · Shenzhen$15.8M Series A
Meidd
December 2021

Meidd is an internet platform dedicated to serving the beauty industry.

Beauty · Shenzhen$12.5M Series Unknown
Datacloak
September 2021

Datacloak is an integrated solution for the core needs of data security and privacy protection for medium and large enterprises.

Cyber Security · Shenzhen$50.0M Series B
Ab&B Biotech
July 2021

Ab&B Biotech focuses on the research and development of innovative human vaccines and multivalent vaccines.

Biotechnology · Taizhou$92.7M Series C
Yaoshibang
June 2021

Yaoshibang is a Chinese B2B pharmaceutical trading platform.

B2B · Guangzhou$270.0M Series E
Duality Biologics
May 2021

Duality Biologics is a company focusing on the discovery, development and commercialization of new modality biologics to provide solutions.

Biopharma · Shanghai$90.0M Series B
cycang.com
May 2021

Cycang is an online portal for skincare, jewelry, and clothing.

Cosmetics · GuangzhouSeries B
EdiGene
April 2021

EdiGene is a biotechnology company that develops genome editing technologies.

Biotechnology · Beijing$61.6M Series B
GenTarGet
January 2021

GenTarGet is a biopharmaceutical research and development company that develops the clinical application of first-in-class biomedicine.

Biotechnology · ShenzhenPrivate Equity
MGI Tech
May 2020

MGI Tech focuses on developing and promoting advanced life science tools for future healthcare.

Biotechnology · Shenzhen$1.0B Series B
Intellifusion
April 2020

Intellifusion develops a vision processor for purposes such as public safety, supercomputing, and AI.

Artificial Intelligence (AI) · Shenzhen$141.0M Series C
360leiliang
March 2020

360leiliang is a S2B self-operated platform that offers fabrics-textile accessories.

E-Commerce · Foochow$2.8M Series A

Where Green Pine Capital Partners invests

Health Care10
Biotechnology8
Medical7
Software5
E-Commerce3
Pharmaceutical3

About Green Pine Capital Partners's portfolio

How many companies has Green Pine Capital Partners invested in?

Green Pine Capital Partners has invested in 124 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does Green Pine Capital Partners invest in?

Green Pine Capital Partners's top investment sectors include Health Care, Biotechnology, Medical, Software, E-Commerce. The firm invests across 43 different industry categories.

What is Green Pine Capital Partners's largest investment?

Among tracked funding rounds, MGI Tech received $1.0B in a Series B round. Green Pine Capital Partners's total known invested capital is $2.8B.

What is the average investment size for Green Pine Capital Partners?

Green Pine Capital Partners's average investment size is $38.4M across its portfolio of 124 companies.

What are Green Pine Capital Partners's most recent investments?

Recent Green Pine Capital Partners portfolio additions include Ruitai Biotechnology, Bluepha, InnerMedical, SiBionics, X-EPIC. These companies were founded in 2020 or later.

Reach the founders behind these 124 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →